
Analysts' Top Industrial Goods Picks: Brookfield Business Partners (BBU), AFRY AB Class B (AFXXF)
There's a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on Brookfield Business Partners (BBU – Research Report), AFRY AB Class B (AFXXF – Research Report) and Verisk Analytics (VRSK – Research Report) with bullish sentiments.
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Brookfield Business Partners (BBU)
In a report issued on April 24, Robert Kwan from RBC Capital maintained a Buy rating on Brookfield Business Partners, with a price target of $30.00. The company's shares closed last Friday at $21.69.
According to TipRanks.com, Kwan is ranked #124 out of 9437 analysts.
Brookfield Business Partners has an analyst consensus of Strong Buy, with a price target consensus of $31.00, representing a 43.7% upside. In a report issued on April 24, Scotiabank also maintained a Buy rating on the stock with a $29.00 price target.
AFRY AB Class B (AFXXF)
In a report issued on April 24, Anders Jafs from Kepler Capital maintained a Buy rating on AFRY AB Class B, with a price target of SEK233.00. The company's shares closed last Thursday at $18.33, equals to its 52-week low of $18.33.
Jafs has an average return of 11.2% when recommending AFRY AB Class B.
According to TipRanks.com, Jafs is ranked #2625 out of 9437 analysts.
AFRY AB Class B has an analyst consensus of Moderate Buy, with a price target consensus of $25.10, which is a 37.0% upside from current levels. In a report issued on April 24, Jefferies also maintained a Buy rating on the stock with a SEK250.00 price target.
Verisk Analytics (VRSK)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Verisk Analytics on April 24 and set a price target of $314.00. The company's shares closed last Friday at $286.05.
According to TipRanks.com, Sabadra is a 4-star analyst with an average return of 3.6% and a 53.8% success rate. Sabadra covers the Financial sector, focusing on stocks such as Dun & Bradstreet Holdings, Intercontinental Exchange, and Cboe Global Markets.
Verisk Analytics has an analyst consensus of Moderate Buy, with a price target consensus of $313.33, implying an 8.9% upside from current levels. In a report issued on April 9, Robert W. Baird also maintained a Buy rating on the stock with a $320.00 price target.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
3 hours ago
- Business Insider
Analysts Offer Insights on Industrial Goods Companies: Oshkosh (OSK), Fastenal Company (FAST) and Generac Holdings (GNRC)
Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Oshkosh (OSK – Research Report), Fastenal Company (FAST – Research Report) and Generac Holdings (GNRC – Research Report). Confident Investing Starts Here: Oshkosh (OSK) Morgan Stanley analyst Angel Castillo maintained a Hold rating on Oshkosh on June 6 and set a price target of $91.00. The company's shares closed last Friday at $109.34. According to Castillo is a 2-star analyst with an average return of -0.2% and a 56.6% success rate. Castillo covers the Industrial Goods sector, focusing on stocks such as Westinghouse Air Brake Technologies, WillScot Mobile Mini Holdings, and Lincoln Electric Holdings. Oshkosh has an analyst consensus of Moderate Buy, with a price target consensus of $115.25, representing a 2.9% upside. In a report issued on May 23, Bernstein also maintained a Hold rating on the stock with a $91.00 price target. Fastenal Company (FAST) Bank of America Securities analyst Sabrina Abrams reiterated a Buy rating on Fastenal Company on June 6 and set a price target of $42.50. The company's shares closed last Friday at $42.06. Abrams has an average return of 9.9% when recommending Fastenal Company. According to Abrams is ranked #5528 out of 9627 analysts. Currently, the analyst consensus on Fastenal Company is a Hold with an average price target of $41.07, representing a -1.6% downside. In a report issued on June 5, William Blair also maintained a Buy rating on the stock. Generac Holdings (GNRC) Citi analyst Vikram Bagri maintained a Buy rating on Generac Holdings on June 6 and set a price target of $138.00. The company's shares closed last Friday at $127.96, close to its 52-week low of $124.76. According to Bagri has 0 stars on 0-5 stars ranking scale with an average return of -20.1% and a 30.0% success rate. Bagri covers the NA sector, focusing on stocks such as Marathon Petroleum, Centrus Energy, and Valero Energy. Currently, the analyst consensus on Generac Holdings is a Moderate Buy with an average price target of $154.44, a 20.0% upside from current levels. In a report issued on June 5, William Blair also maintained a Buy rating on the stock.


Business Insider
a day ago
- Business Insider
Analysts' Opinions Are Mixed on These Healthcare Stocks: Quince Therapeutics (QNCX) and Moderna (MRNA)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quince Therapeutics (QNCX – Research Report) and Moderna (MRNA – Research Report). Confident Investing Starts Here: Quince Therapeutics (QNCX) In a report issued on June 4, Jason McCarthy from Maxim Group maintained a Buy rating on Quince Therapeutics, with a price target of $6.00. The company's shares closed last Friday at $1.17. According to McCarthy 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -19.2% and a 28.3% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Brainstorm Cell Therapeutics, and SELLAS Life Sciences Group. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Quince Therapeutics with a $6.67 average price target. Moderna (MRNA) In a report released today, Matt Phipps from William Blair reiterated a Hold rating on Moderna. The company's shares closed last Friday at $27.46. According to Phipps is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -8.1% and a 41.7% success rate. Phipps covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Ultragenyx Pharmaceutical, and Janux Therapeutics Inc. Currently, the analyst consensus on Moderna is a Hold with an average price target of $49.29, an 88.1% upside from current levels. In a report issued on May 27, Barclays also maintained a Hold rating on the stock with a $40.00 price target.


Business Insider
2 days ago
- Business Insider
Analysts Offer Insights on Consumer Cyclical Companies: Five Below (FIVE) and Autoliv (ALV)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Five Below (FIVE – Research Report) and Autoliv (ALV – Research Report). Confident Investing Starts Here: Five Below (FIVE) Barclays analyst Seth Sigman maintained a Hold rating on Five Below on June 5 and set a price target of $120.00. The company's shares closed last Friday at $127.35. According to Sigman 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.0% and a 53.9% success rate. Sigman covers the NA sector, focusing on stocks such as Driven Brands Holdings, Floor & Decor Holdings, and Advance Auto Parts. Five Below has an analyst consensus of Moderate Buy, with a price target consensus of $118.63, which is a -7.0% downside from current levels. In a report issued on May 28, Citi also maintained a Hold rating on the stock with a $121.00 price target. Autoliv (ALV) Kepler Capital analyst Alexandre Raverdy maintained a Buy rating on Autoliv on June 5 and set a price target of $100.00. The company's shares closed last Friday at $105.62. According to Raverdy is ranked #5408 out of 9607 analysts. Autoliv has an analyst consensus of Strong Buy, with a price target consensus of $111.31, a 4.8% upside from current levels. In a report issued on May 28, UBS also maintained a Buy rating on the stock with a $123.00 price target.